<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03967600</url>
  </required_header>
  <id_info>
    <org_study_id>16-19770</org_study_id>
    <nct_id>NCT03967600</nct_id>
  </id_info>
  <brief_title>Clinical and Biological Characteristics of Hidradenitis Suppurativa</brief_title>
  <official_title>Clinical and Biological Characteristics of Hidradenitis Suppurativa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly
      understood and understudied. As a result, little is known about disease prognosis and few
      effective treatments exist for this condition. This prospective observational cohort study
      aims to comprehensively characterize the clinical and biological features of HS. The results
      of this research will provide a basis for the development of an HS clinical classification
      system and identification of potential treatments for HS.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 15, 2016</start_date>
  <completion_date type="Anticipated">July 15, 2026</completion_date>
  <primary_completion_date type="Anticipated">July 15, 2026</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>The primary aim of this study is to identify clinical and biologic characteristics of hidradenitis suppurativa.</measure>
    <time_frame>2016-2026</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary aims include correlating alterations in clinical and biological characteristics with disease status, and identifying genetic variants that predict disease progression or response to therapy.</measure>
    <time_frame>2016-2026</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Hidradenitis Suppurativa</condition>
  <arm_group>
    <arm_group_label>Hidradenitis Suppurativa Patients</arm_group_label>
    <description>Patients with physician diagnosed Hidradenitis Suppurativa</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Volunteers</arm_group_label>
    <description>Healthy volunteers without any skin conditions or recent history of antibiotic use.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Hidradenitis Suppurativa
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Hidradenitis Suppurativa Patients

        Inclusion Criteria:

          1. Age 13 years or older

          2. Diagnosis of HS clinically-confirmed by a physician

        Exclusion Criteria:

        1. Inability to give informed consent or have a parent/guardian who is able and willing to
        give informed consent.

        Healthy Volunteer

        Inclusion Criteria:

          1. No history of chronic skin conditions

          2. No recent history of antibiotic use

        Exclusion Criteria:

        1. Inability to give informed consent or have a parent/guardian who is able and willing to
        give informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Haley B Naik, MD, MHSc, FAAD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maia Paul, MPH</last_name>
    <phone>415-502-4741</phone>
    <email>Maia.Paul@ucsf.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maia Paul, MPH</last_name>
      <phone>415-502-4741</phone>
      <email>Maia.Paul@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Haley B Naik, MD, MHSc, FAAD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>May 27, 2019</study_first_submitted>
  <study_first_submitted_qc>May 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2019</study_first_posted>
  <last_update_submitted>February 26, 2020</last_update_submitted>
  <last_update_submitted_qc>February 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hidradenitis Suppurativa</mesh_term>
    <mesh_term>Hidradenitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

